Clinical development of kinase inhibitors for the treatment of differentiated thyroid cancer.


The incidence of thyroid cancer is growing at a rapid rate, with the majority of cases being differentiated thyroid cancers. Although a significant number of patients with localized disease are cured, a paucity of effective therapies currently exists for patients with recurrent and/or metastatic disease. The translational bridging of critical biologic… (More)

2 Figures and Tables


  • Presentations referencing similar topics